睿昂基因：关于使用自有资金支付募投项目所需资金并以募集资金等额置换的公告

Core Viewpoint - Ruiang Gene announced the approval of a proposal to use its own funds to pay for fundraising project expenses and to replace these with equivalent amounts from raised funds [2] Group 1: Company Actions - The company will hold its third board meeting on November 13, 2025, to discuss the proposal [2] - The proposal allows the company and its subsidiaries to use self-owned funds for project expenses during the implementation period [2] - The equivalent amount of funds used will be transferred from the fundraising account to the company's own funds account, treating this amount as project usage funds [2]